Nyon, Switzerland – An increasing number of primary care physicians and orthopaedists around the world are using the WHO Fracture Risk Assessment Tool (FRAX®) to predict their patients’ 10-year probability of a fragility fracture based on clinical risk factors, with or without BMD measurement. FRAX® aids doctors in targeting treatment more accurately to people in need while helping to avoid unnecessary treatment or DXA scans in those at low risk.
FRAX® has been made available as an iPhone and iPad application in order to allow access to the calculator in clinical settings without Internet access. In a recent review of the iPhone application by www.imedicalapps.com , the reviewer praised the download for its ease of use and attractive interface. FRAX® is developed in partnership with the International Osteoporosis Foundation (IOF), the leading non-profit, non governmental organization dedicated to the global fight against osteoporosis. Profits to IOF from FRAX® downloads support the Foundation’s important educational programs and projects.
Download the application at http://itunes.apple.com/us/app/frax/id370146412?mt=8
The latest Web version 3.2 of FRAX® has been redesigned for more flexibility and the number of languages has been recently expanded to include Arabic and Turkish. With Korean soon to be added, FRAX® will be accessible in a total of 15 languages. The tool is now available for 30 country models, with the most recent additions being Jordan, Malta, Philippines and Singapore.
Hosted by the University of Sheffield in the UK, the FRAX® website at http://www.sheffield.ac.uk/FRAX/ currently receives 7000 visitors per day (some 73 million hits per year) with the number of users growing steadily. The incorporation of FRAX® into an increasing number of practice guidelines has been a key development in boosting usage of the tool around the world. Most recently, FRAX® has been incorporated in newly released guidelines by the U.S. Preventive Services Task Force.
The ultimate aim of the clinician in the management of osteoporosis should be to reduce the risk of fractures. Treatment decisions must be made through good clinical judgment and through improved identification of patients at high risk. FRAX® is a simple web-tool that integrates clinical information in a quantitative manner to predict a 10-year probability of major osteoporotic fracture for both women and men in different countries. Developed at the World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK, the tool assists primary health care providers to better target people in need of intervention, improving the allocation of healthcare resources towards patients most likely to benefit from treatment. The tool can be accessed free of charge at http://www.shef.ac.uk/FRAX/ or via iPhone Application.
The International Osteoporosis Foundation (IOF) is a non profit, nongovernmental umbrella organization dedicated to the worldwide fight against osteoporosis, the disease known as “the silent epidemic”. IOF’s members – committees of scientific researchers, patient, medical and research societies and industry representatives from around the world – share a common vision of a world without osteoporotic fractures. IOF now represents 196 societies in 93 locations. http://www.iofbonehealth.org